Skip to content

Addition of Tramadol as as an adjuvant in Axillary Brachial Plexus Block in Forearm and Hand surgeries

Efficacy Of Tramadol As An Adjuvant To Bupivicaine In Axillary Brachial Plexus Block In Patients undergoing Forearm and Hand surgeries , A Prospective Double Blinded Randomised Controlled study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071194
Enrollment
82
Registered
2024-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: V239- Unspecified motorcycle rider injured in collision with car, pick-up truck or van in traffic accident

Interventions

Intervention1: GROUP-BT:USG guided Axillary brachial plexus block with 24ml of 0.5% Bupivicaine along with Tramadol 1ml-50mg: USG guided Axillary brachial plexus block with 24ml of 0.5% Bupivicaine al

Sponsors

Bandari Vamshi Sai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA 1 and ASA 2 patients of either sex 2.patients age between 20 to 60 years old 3.patients undergoing forearm and hand surgeries

Exclusion criteria

Exclusion criteria: 1.patients refusal 2.patients with known hypersensitivity to known local anaesthetic drug 3.patients with bleeding diathesis ,uncontrolled diabetes mellitus and severe hepatorenal disease 4.patients with epilepsy and mentally unstable 5.pregnant and lactating women 6.local site infection,peripheral vascular disease and neurological disease 7.patients on chronic analgesic therapy and anti coagulants 8.patients less than 40 kgs

Design outcomes

Primary

MeasureTime frame
To compare the duration of analgesia after addition of tramadol 50mg with 0.5% Bupivicaine in both the groups.Timepoint: to note intra operative vitals at 0,5,10,15,30,45,60,90,120 minutes

Secondary

MeasureTime frame
To compare the duration of sensory and motor block.Timepoint: to not vas at 0,30,60,120 minutes,4,8,16,24 hours

Countries

India

Contacts

Public ContactJyoti Petkar

Rajarajeswari Medical College And Hospital

jokiran2009@gmail.com7726899533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026